Lipidomic analysis revealed a decrease in diacylglycerols (DGs) and ceramides, implicating pathways such as sphingolipid and phosphatidylinositol metabolism, in addition to HIF-1α signaling, insulin resistance, and diabetic complications. The gene discussed is HIF1A; the disease is Insulin resistance.